Evidence map›Paper›PMID 31660246›Full record

ArticleJournal of clinical and translational science2019

Community advisory boards: Experiences and common practices of clinical and translational science award programs.

M Kathryn Stewart, Beatrice Boateng, Yvonne Joosten, Dana Burshell, Hilary Broughton, Karen Calhoun, Anna Huff Davis, Rachel Hale, Nicola Spencer, Patricia Piechowski and 1 more

Abstract read
In one paragraph

Article in Journal of clinical and translational science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

M Kathryn StewartHealth Policy and Management, Fay W. Boozman College of Public Health, Translational Research Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Beatrice BoatengDepartment of Pediatrics, College of Medicine, Translational Research Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.ORCID https://orcid.org/0000-0001-8977-0666
Yvonne JoostenInstitute for Medicine and Public Health, Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University, Nashville, TN, USA.
Dana BurshellSouth Carolina Clinical and Translational Research Institute, Medical University of South Carolina, Charleston, SC, USA.
Hilary BroughtonInstitute of Clinical and Translational Sciences, Washington University in St. Louis, St. Louis, MO, USA.
Karen CalhounMichigan Institute for Clinical and Health Research, University of Michigan, Ann Arbor, MI, USA.
Anna Huff DavisTranslational Research Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Rachel HaleTranslational Research Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Nicola SpencerTranslational Research Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Patricia PiechowskiMichigan Institute for Clinical and Health Research, University of Michigan, Ann Arbor, MI, USA.
Laura JamesDepartment of Pediatrics, College of Medicine, Translational Research Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Michigan Institute for Clinical and Health Research (MICHR)UL1TR002240 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUMENG, JULIE C, MASHOUR, GEORGE ALEXANDER · 2017 to 2022
$54.9M
South Carolina Clinical & Translational Research Institute (SCTR)UL1TR001450 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T., FLUME, PATRICK A · 2015 to 2024
$41.1M
Expanding Translational Research in ArkansasUL1TR003107 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI JAMES, LAURA P · 2019 to 2023
$21.6M
The role of prisons in community spread of COVID-19: Disparate epidemiologic profiles in rural, racial/ethnic minority, and low socioeconomic US countiesU54MD002329 · NIMHD · UNIV OF ARKANSAS FOR MED SCIS · PI RACZYNSKI, JAMES M · 2017 to 2022
$7.7M
Expanding Translational Research in ArkansasU54TR001629 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI JAMES, LAURA P · 2017 to 2017
$3.5M
NCATS NIH HHS U54 TR001629NCATS NIH HHS UL1 TR001450NCATS NIH HHS UL1 TR002240NCATS NIH HHS UL1 TR002243NCATS NIH HHS UL1 TR002345NCATS NIH HHS UL1 TR003107NIMHD NIH HHS U54 MD002329
6 · The paper itself

Abstract

Community advisory boards (CABs) are a valuable strategy for engaging and partnering with communities in research. Eighty-nine percent of Clinical and Translational Science Awardees (CTSA) responding to a 2011 survey reported having a CAB. CTSAs' experiences with CABs are valuable for informing future practice. This study was conducted to describe common CAB implementation practices among CTSAs; document perceived benefits, challenges, and contributions; and examine their progress toward desirable outcomes. A cross-CTSA collaborative team collected survey data from respondents representing academic and/or community members affiliated with CTSAs with CABs. Data representing 44 CTSAs with CABs were analyzed using descriptive statistics. A majority of respondents reported practices reflecting respect for CAB members' expertise and input such as compensation (75%), advisory purview beyond their CTSA's Community Engagement program (88%), and influence over CAB operations. Three-quarters provide members with orientation and training on roles and responsibilities and 89% reported evaluating their CAB. Almost all respondents indicated their CTSA incorporates the feedback of their CABs to some degree; over half do so a lot or completely. This study profiles practices that inform CTSAs implementing a CAB and provide an evaluative benchmark for those with existing CABs.

Indexed as

best practicesCommunity advisory boardcommunity engagementcommunity partnershipsimplementationsurvey

Identifiers

PMID31660246
PMCPMC6813515

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.